Direktorat Registrasi ObatValid

CEFTAZIDIME PENTAHYDRATE

Claim this product
BPOM Number
GKL1219929144A1
Approved
21 November 2024
Expiry
31 July 2022
Form
SERBUK INJEKSI; 1,340 G

About This Registration

CEFTAZIDIME PENTAHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1219929144A1. Its current registration status is Valid, with the licence valid until 31 July 2022. The product is registered to PHAPROS TBK and manufactured by PHAPROS TBK - INDONESIA. BPOM first approved this registration in December 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 10 VIAL @ 1 G
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

CEFTAZIDIME PENTAHYDRATE BUFFERED WITH SODIUM CARBONATE

Market Intelligence

Owner Portfolio
PHAPROS TBK holds 210 BPOM registrations
Manufacturer Scale
PHAPROS TBK - INDONESIA produces 208 registered products
Registration Age
Registered for 6 years, 8 months
Expiry Status
Expired 1518 days ago

FDA Cross-Reference

via openFDA
Generic Name
CEFTAZIDIME
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1